Naringenin and quercetin - Potential anti-HCV agents for NS2 protease targets

Natural Product Research

Volumn 30, Issue 4, 2016, Pages 464-468

  Sajitha Lulu, S ^a   Thabitha, A ^a   Vino, S ^a   Mohana Priya, A ^a   Rout, Madhusmita ^a  

^a VIT UNIVERSITY   (India)

Author keywords

cirrhosis; hepatocellular; naringenin; phytocompounds; quercetin

Indexed keywords

ANTIVIRUS AGENT; FLAVANONE DERIVATIVE; LIGAND; NARINGENIN; NS2 PROTEIN, HEPATITIS C VIRUS; QUERCETIN; VIRAL PROTEIN;

CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; HEPACIVIRUS; MOLECULAR DOCKING;

ANTIVIRAL AGENTS; FLAVANONES; HEPACIVIRUS; LIGANDS; MOLECULAR DOCKING SIMULATION; QUERCETIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84955172217     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2015.1020490     Document Type: Article

References (13)

1. Chander R, Singh K, Khanna AK, Kaul SM, Puri A, Saxena R, Bhatia G, Rizvi F, Rastogi AK. 2004. Antidyslipidemic and antioxidant activities of different fractions ofTerminalia arjuna stem bark. Indian J Clin Biochem. 19:141-148. doi:10.1007/BF02894274.
2. Chang WS, Chang YH, Lu FJ, Chiang HC. 1994. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res. 2:501-506.
3. Erdtmann L, Franck N, Lerat H, Le Seyec J, Gilot D, Cannie I, Gripon P, Hibner U, Guguen-Guillouzo C. 2003. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem. 278:18256-18264. doi:10.1074/jbc.M209732200.
4. Franck N, Le Seyec J, Guguen-Guillouzo C, Erdtmann L. 2005. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J Virol. 79:2700-2708. doi:10.1128/JVI.79.5. 2700-2708.2005.
5. Handa S, Sharma A. 1990. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. Indian J Med Res. 92:276-283.
6. Heibatollah S, Reza NM, Izadpanah G, Sohailla S. 2008. Hepatoprotective effect of Cichorium intybus on CCl4-induced liver damage in rats. Afr J Biochem Res. 2:141-144.
7. Rahim ZB, Rahman MM, Saha D, Hosen SZ, Paul S, Kader S. 2012. Ethnomedicinal plants used against jaundice in Bangladesh and its economical prospects. Bull Pharm Res. 2:91-105.
8. Santolini E, Migliaccio G, Monica LN. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 68:3631-3641.
9. Tomei L, Failla C, Vitale RL, Bianchi E, De Francesco R. 1996. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J Gen Virol. 77:1065-1070. doi:10.1099/0022-1317-77-5-1065.
10. Wagner H, Geyer B, Kiso Y, Hikino H, Rao GS. 1986. Coumestans as the main active principles of the liver drugs. Eclipta alba and Wedelia calendulacea 1. Planta Med. 52:370-374. doi:10.1055/s-2007-969188.
11. Yamaga AK, Ou JH. 2002. Membrane topology of the hepatitis C virus NS2 protein. J Biol Chem. 277:33228-33234. doi:10.1074/jbc.M202304200.
12. Yang XJ, Liu J, Ye L, Liao QJ, Wu JG, Gao JR, She YL, Wu ZH, Ye LB. 2006. HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression. Virus Res. 121:134-143. doi:10.1016/j.virusres.2006.02.004.
13. Zhao W, Xue R, Zhou ZX, Kong WJ, Jiang JD. 2008. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. Biomed Pharmacother. 62:730-731. doi:10.1016/j.biopha.2008.01.007.